Civic AI
Procurement intelligence
Federal contract award
REGENERON ANTI-MERS ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT
REGENERON PHARMACEUTICALS INC · Department of Health and Human Services
- Value
- $8,601,629
- Start
- Aug 9, 2016
- End
- Sep 30, 2022
- Action date
- Mar 19, 2026
- PIID
- HHSO100201600023C
- Status
- completed
- NAICS
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- Place of performance
- TARRYTOWN, NY
- Award type
- DEFINITIVE CONTRACT
Description
REGENERON ANTI-MERS ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT
Need modifications, related awards, and vendor peers? Open the full award workspace.